Atlas Trials

Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

Clinical trial NCT03314051 · COMPLETED

Trial details

NCT number
NCT03314051
Sponsor
Taichung Veterans General Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Nasopharyngeal CarcinomaEBV Related Carcinoma
Start date
2012-05-02
Primary completion
2013-05-01
Enrollment
366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.